Yale University /ID# 144170 — New Haven, Connecticut

Yale University /ID# 144170 is a clinical research site located in New Haven, Connecticut, United States 06510.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Yale University /ID# 144170 has participated in 1 clinical trials.

Therapeutic areas: Glioblastoma, Gliosarcoma.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Yale University /ID# 144170?

Yale University /ID# 144170 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Yale University /ID# 144170 conducted?

Yale University /ID# 144170 has 1 clinical trials on record. Their work covers Glioblastoma, Gliosarcoma.

Is Yale University /ID# 144170 accredited by Crixeo Health?

Yale University /ID# 144170 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Yale University /ID# 144170?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.